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Background: The evidence that higher levels of physical activity and/or lower levels of physical inactivity are
associated with beneficial health-related outcomes stems mainly from observational studies. Findings from these
studies often differ from randomised controlled trials and systematic reviews currently demonstrate mixed results,
due partly to heterogeneity in physical activity interventions, methodologies used and populations studied. As a
result, translation into clinical practice has been difficult. It is therefore essential that an overview is carried out to
compare and contrast systematic reviews, and to identify those physical activity interventions that are the most
effective in preventing and/or treating major chronic disease. This protocol has been registered on PROSPERO 2013:
CRD42013003523.
Methods: We will carry out an overview of Cochrane systematic reviews. We will search the Cochrane Database of
Systematic Reviews for systematic reviews of randomised controlled trials that have a primary focus on
disease-related outcomes. We will restrict reviews to those in selected major chronic diseases. Two authors will
independently screen search outputs, select studies, extract data and assess the quality of included reviews using
the assessment of multiple systematic reviews tool; all discrepancies will be resolved by discussing and reaching a
consensus, or by arbitration with a third author. The data extraction form will summarise key information from each
review, including details of the population(s) (for example, disease condition), the context (for example, prevention,
treatment or management), the participants, the intervention(s), the comparison(s) and the outcomes. The primary
outcomes of interest are the prevention of chronic disease and/or improved outcomes, in the treatment or
management of chronic disease. These outcomes will be summarised and presented for individual chronic diseases
(for example, any change in blood pressure in hypertension or glucose control in diabetes). Secondary outcomes of
interest are to describe the structure and delivery of physical activity interventions across chronic disease conditions
and adverse events associated with physical activity.
Discussion: We anticipate that our results could inform researchers, guideline groups and policymakers of the most
efficacious physical activity interventions in preventing and/or managing major chronic disease.
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The World Health Organization (WHO) reported that
physical inactivity is the fourth leading risk factor for
global mortality, accounting for 6% of deaths globally
[1]. A more recent analysis of the worldwide burden of
disease further estimated that physical inactivity was re-
sponsible for 6% of the incidence of coronary heart dis-
ease, 7% of type 2 diabetes, 10% of breast cancer, and
10% of colon cancer. The study went on to conclude
that if physical inactivity decreased by 25% then more
than 1.3 million deaths could be averted every year [2].
As a result, both the UK government and relevant pro-
fessional bodies recommend that health professionals
take a more active role in encouraging patients to lead
healthier lifestyles, including offering advice on smoking,
alcohol consumption, diet and physical activity/exercise
at every patient contact [3,4]. It was further hoped that
the recent London Olympic Games could have been be
used to improve understanding of the benefits of exer-
cise and physical activity in the prevention and treat-
ment of chronic conditions [5]. However, the evidence
for a legacy of an automatic increase in physical activity
is mixed [6].
Nevertheless, the WHO recommends that all adults
should aim for 30 minutes of moderate activity daily on
at least five days over a one week period, with slight var-
iants of these recommendations for children (under 5s
and 5 to 18 years) and older adults (aged 65+) [1]. These
recommendations have been adopted in the UK, Europe
and North America [7-9].
Data to support these recommendations were predom-
inately sourced from epidemiological and observational
studies providing evidence that higher levels of physical
activity and/or lower levels of physical inactivity are asso-
ciated with beneficial health-related outcomes across a
wide range of populations [10-18]. These findings have
been used to inform a large number of randomised con-
trolled trials (RCTs) assessing the preventative, treatment
or management benefits of physical activity and exercise
interventions in specific populations, particularly those at
risk of developing or already diagnosed with chronic dis-
ease [19-22]. Systematic reviews of these RCTs have been
conducted to appraise, summarise and collate them (for
example, the Cochrane Database of Systematic Reviews).
Systematic reviews demonstrate mixed results, with some
reviews of RCTs showing a benefit from physical activity
whilst others do not find any benefit from physical activity
for different chronic diseases [23-27]. For example, a 2004
Cochrane review of eight RCTs assessing the effects of
short- and long-term, land- and water-based aerobic and
aerobic with strength exercise programmes found there
was no increase in pain or decrease in functional capacity
but there was little improvement in aerobic capacity or
muscle strength [24].Conversely, a 2008 Cochrane review assessing the role
of exercise, dietary or exercise plus dietary interventions
for preventing type 2 diabetes mellitus reported that ex-
ercise only interventions were no better than usual care
or diet alone interventions. Moreover, no studies have
reported relevant data for diabetes- and cardiovascular-
related morbidity, mortality or quality of life [23].
Decision-makers are therefore faced with a plethora of
reviews that contain data of varying quality and scope,
since some similar chronic disease conditions have been
reviewed more than once.
Objectives of this overview
We will carry out an overview of existing Cochrane sys-
tematic reviews. Overviews are suggested as a logical
and appropriate step for comparing and contrasting sep-
arate reviews and are particularly useful where there is
ambiguity, which could be removed by systematic ap-
praisal and summarising [28]. Using this methodology
our objective is to summarise the current best evidence
for the use of physical activity in the prevention and/or
treatment of selected chronic diseases and discuss how




Our protocol is registered on PROSPERO 2013 (CRD4
2013003523) [29].
Data sources and search strategy
Two authors (NR and DN) devised the search strategy
of the Cochrane Database of Systematic Reviews
(Cochrane Library, Wiley) based on a combination of
free-text keywords and subject headings that describe
exercise and the disease categories of interest. Date and
language restrictions will be determined as per the cri-
teria for individual reviews. Table 1 shows the search
strategy we will use to identify reviews. Since Cochrane
reviews strive for methodological rigour and are regu-
larly updated, we do not propose to include non-
Cochrane reviews within this overview.
Selection of reviews
Two authors (DN and KRM) will independently review
the results of the above search strategy and select re-
views that meet the inclusion criteria (as outlined
below). Any disagreement will be resolved by discussion
with a third author (CH). References will be managed
using Endnote v5.0 (Thomson Reuters).
Types of reviews
We will include any review of randomised controlled
trials that examine the effects of a physical activity
Table 1 Cochrane Library search strategy
Id Criteria
#1 MeSH descriptor: [Exercise] explode all trees
#2 MeSH descriptor: [Exercise Therapy] explode all trees
#3 MeSH descriptor: [Motor Activity] explode all trees
#4 MeSH descriptor: [Sports] explode all trees
#5 MeSH descriptor: [Recreation] explode all trees
#6 MeSH descriptor: [Dancing] explode all trees
#7 “exercise”:ti,ab,kw
#8 “physical activity” or “motor activity”:ti,ab,kw
#9 ((physical or resistance or strength) near training):ti,ab,kw
#10 training:ti
#11 sport*:ti,ab,kw
#12 walk or walking or bicycle* or cycling or run or jog or running or
jogging:ti,ab,kw
#13 athlet* or basketball or cricket or dance or dancing or football* or
hockey or netball or rugby or ski or skiing or soccer or swim* or
volleyball:ti,ab,kw
#14 “physical education” or “physical training” or “physical fitness”:ti,ab,kw
#15 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or
#12 or #13 or #14
#16 MeSH descriptor: [Cardiovascular Diseases] explode all trees
#17 MeSH descriptor: [Heart Diseases] explode all trees
#18 MeSH descriptor: [Vascular Diseases] explode all trees
#19 MeSH descriptor: [Diabetes Mellitus] explode all trees
#20 MeSH descriptor: [Renal Insufficiency, Chronic] explode all trees
#21 MeSH descriptor: [Neoplasms by Site] explode all trees
#22 MeSH descriptor: [Neoplasms] explode all trees
#23 MeSH descriptor: [Lung Diseases, Obstructive] explode all trees
#24 MeSH descriptor: [Arthritis, Rheumatoid] explode all trees
#25 MeSH descriptor: [Osteoporosis] explode all trees
#26 cardiovascular or cardio-vascular or cvd:ti
#27 ((cardiovascular or cardio-vascular) near disease*):ti,ab,kw
#28 ((cardiovascular or cardio-vascular) near (event* or outcome* or
risk*)):ti,ab,kw (Word variations have been searched)
#29 coronary or heart or chd or myocardial:ti (Word variations have been
searched)
#30 ((coronary or heart) near disease*):ti,ab,kw
#31 ((coronary or heart) near (event* or outcome* or risk*)):ti,ab,kw
#32 (ischaemic or ischemic or ischaemia or ischemia):ti (Word variations
have been searched)
#33 ((ischaemic or ischemic or ischaemia or ischemia) near disease*):ti,ab,
kw
#34 ((ischaemic or ischemic or ischaemia or ischemia) near (event* or
outcome* or risk*)):ti,ab,kw
#35 myocardial infarct*:ti,ab,kw
#36 vascular:ti (Word variations have been searched)
#37 vascular near disease*:ti,ab,kw
#38 (vascular near (event* or outcome* or risk*)):ti,ab,kw
Table 1 Cochrane Library search strategy (Continued)
#39 stroke:ti,ab,kw
#40 atherosclero* or arteriosclero*:ti,ab,kw
#41 “peripheral artery” or “peripheral arterial”:ti,ab,kw
#42 “heart failure”:ti,ab,kw
#43 thrombo* or embolism or embolus or PE or DVT:ti,ab,kw
#44 hypertens* or anti-hypertens* or antihypertens*:ti,ab,kw
#45 diabet*:ti,ab,kw
#46 rheumat* or arthritis:ti,ab,kw
#47 osteoporosis:ti,ab,kw
#48 MeSH descriptor: [Overweight] explode all trees
#49 obes* or overweight:ti,ab,kw
#50 neoplas* or cancer* or carcinoma* or tumor* or tumour*:ti,ab,kw
#51 ((kidney or renal) near (disease* or failure or insufficiency)):ti,ab,kw
#52 MeSH descriptor: [Hypertension] explode all trees
#53 MeSH descriptor: [Blood Pressure] explode all trees
#54 MeSH descriptor: [Mental Disorders] this term only
#55 MeSH descriptor: [Depressive Disorder] explode all trees
#56 MeSH descriptor: [Depression] explode all trees
#57 depress*:ti,ab,kw (Word variations have been searched)
#58 ((mental* or mood) near/3 (ill* or disorder* or health)):ti (Word
variations have been searched)
#59 MeSH descriptor: [Dementia] explode all trees
#60 dementia* or alzheimer*:ti,ab,kw (Word variations have been
searched)
#61 #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25
or #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or
#35 or #36 or #37 or #38 or #39 or #40 or #41 or #42 or #43 or #44
or #45 or #46 or #47 or #48 or #49 or #50 or #51 or #52 or #53 or
#54 or #55 or #56 or #57 or #58 or #59 or #60
#62 #15 and #61
#63 MeSH descriptor: [Heart Diseases] explode all trees and with qualifiers:
[Rehabilitation - RH]
#64 MeSH descriptor: [Vascular Diseases] explode all trees and with
qualifiers: [Rehabilitation - RH]
#65 #62 or #63 or #64
MeSH, medical subject heading.
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chronic disease (see Types of participants) and that have
a primary focus on disease-related outcomes.
Types of participants
Participants will be adults at risk of developing and/or
already diagnosed with major chronic disease(s) as de-
fined by the reviews. We will restrict reviews to those re-
lating to the four areas highlighted in the 2008–2013
WHO non-communicable disease action plan [30]: (1)
cardiovascular disease including cerebrovascular disease,
heart disease (including congenital heart disease, coron-
ary heart/artery disease (atherosclerosis), heart failure
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chaemic heart disease), peripheral arterial disease, deep
vein thrombosis and pulmonary embolism; (2) cancer
(for the purpose of this review we will limit this to breast
and prostate cancer); (3) chronic respiratory disease
including asthma and chronic obstructive pulmonary
disease and (4) diabetes. We will also include chronic
kidney disease, obesity, osteoporosis arthritis (including
rheumatoid and psoriatic arthritis), depression and de-
mentia. Since the overview is based on Cochrane Reviews
we will be led by their inclusion criteria and discuss the
limitations of the inclusion criteria accordingly.
Types of intervention
We will consider all types of interventions or combina-
tions of interventions involving physical activity, exer-
cise, rehabilitation (involving physical activity and/or
exercise) and sport in the prevention or treatment of se-
lected major chronic diseases. These interventions can
be compared with either control interventions (such as
standard or usual care) or with another intervention
aimed at preventing or treating major chronic disease
(for example, diet for overweight or obese people).
Types of outcomes
Primary outcomes
The primary outcomes of interest are the prevention of
chronic disease and improved outcomes, treatment or
management of chronic disease. These outcomes will be
summarised and presented for individual chronic dis-
eases; for example the incidence of diabetes, reduced
mortality in coronary heart disease, the lowering of
blood pressure in hypertension, better glucose control in
diabetes or improved symptoms of depression.
Secondary outcomes
The secondary outcomes are: the structure and delivery
of physical activity interventions across chronic disease
conditions; adverse events (such as injury related to
physical activity, exercise, rehabilitation or sports); with-
drawals due to the physical activity intervention; and ad-
herence to the intervention(s), particularly the fidelity
and drop-out rate over time and the relation between
drop-out and mode, intensity and volume of physical ac-
tivity. Where possible, we will also report on the cost ef-
fectiveness of physical activity interventions.
Data extraction and analysis
The methodology for data extraction and analysis will be
based on the guidance in the Cochrane Handbook of Sys-
tematic Reviews of Interventions [31]. The full text
of selected reviews will be obtained. Two authors (DN
and KRM) will independently extract descriptive and
outcome data from each included review using apredefined data extraction form, resolving any discrep-
ancies by discussion and consensus; failing which, a third
author (CH) will arbitrate. The data extraction form will
summarise key information from each review, including
details of the population(s) (for example, disease condi-
tion), the context (for example, prevention, treatment or
management), the participants, the intervention(s) in-
cluding method of delivery and duration, the compari-
son(s), outcomes and duration of follow up. Outcomes
wherever possible will include both beneficial and harm-
ful effects of the intervention(s). These data will be
presented in a series of summary tables and figures.
Assessment of methodological quality of
included reviews
Two reviewers (DN and KRM) will independently assess
the methodological quality of included studies using the
Assessment of Multiple Systematic Reviews (AMSTAR)
tool [28,32] with adapted items from the Grading of
Recommendations Assessment, Development and Evalu-
ation (GRADE). We will not exclude reviews based on
AMSTAR, but will conduct sensitivity analysis if applic-
able to explore the consequences of synthesising reviews
of differing quality. We will summarise the quality of the
evidence in included reviews based on the risk of bias
and any summary of findings tables within them [27].
Dealing with missing data
We will extract reasons for missing data as reported by
the original reviews. We will report the number of stud-
ies that perform intention-to-treat or per protocol ana-
lyses if provided by the original reviews.
Data synthesis
We will present data as a narrative synthesis supported
by tabulated data of the statistical outcomes reported in
the original reviews. Comparisons presented will be de-
termined by the data in the original reviews. Where pos-
sible we will group data by chronic disease condition
and whether reviews focused on prevention or treatment
and management. We aim to ensure in all cases that we
compare interventions that reflect clinical decisions.
The outcomes of interest will be either dichotomous
or continuous. We will report risk ratios and their corre-
sponding 95% confidence intervals and P values for
dichotomous outcomes, and mean differences for con-
tinuous outcomes. Flow diagrams will be used to sum-
marise the study selection process. We will use
summary tables and figures to present results in a struc-
tured and clear format, which will enhance the textual
commentary. We will also use the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses
(PRISMA) statement [33] as a framework to guide our
selection of items for our systematic review of reviews.
Nunan et al. Systematic Reviews 2013, 2:56 Page 5 of 6
http://www.systematicreviewsjournal.com/content/2/1/56The reporting of outcomes without quantitative data
will be descriptive. Lastly, we will provide a list of
excluded studies with reasons for exclusion.
Sensitivity analysis
We will conduct sensitivity analysis based on GRADE
level, by comparing results from all studies against those
excluding low-quality studies.
Sub-group analysis
We will classify the reviews into sub-groups based on
the type of intervention (prevention or treatment/man-
agement), setting (for example, primary care, secondary
care or community based) and type of physical activity
(for example, structured or unstructured, aerobic or re-
sistance and supervised or unsupervised) to aid inter-
pretation and to impose a clinically relevant structure
(for example, age over 75s and disease severity, where
this is reported in the original review).
Reliability of the outcomes
Where reviews have pooled outcomes (that is, meta-
analyses), the heterogeneity of the evidence for each pri-
mary outcome will be examined by summarising the
range of the I2 statistic. Where reviews have not pooled
outcomes, we will critically evaluate the role of the out-
come measure by comparing the sensitivity and stability
of measures across the included reviews where possible.
Summary of the evidence base
We will analyse and discuss limitations in the evidence
base including overall methodological quality of the indi-
vidual systematic reviews and the number of participants
within each review. This will include an analysis of the
strongest and weakest evidence for each chronic disease
condition and intervention, taking into account the
strength of the summary results. We will also analyse
and discuss barriers to physical activity interventions
and implementation in clinical practice.
Discussion
Expected significance of the study
The findings of this overview of reviews will have impli-
cations for policy, practice and research. Our results will
provide clarity about the best evidence available on
physical activity in the prevention and/or treatment of
major chronic disease compared to usual care, placebo
or no intervention. They will inform clinicians and
policymakers of the disease conditions for which phys-
ical activity intervention provides a clear prevention
and/or management benefit, and those for which there
is no clear benefit or where there is a lack of evidence of
benefit. If sufficient data can be extracted, the findings
should also indicate the type, intensity, volume, durationand setting (that is, primary care, secondary care or
community based) of physical activity interventions that
result in improved health status but also the conditions
under which physical activity may cause harm (that is,
injury).
The overview will identify specific considerations that
would need to be taken into account for future studies,
such as study location; content of physical activity inter-
ventions (for example, type, intensity and duration); be-
havioural aspects; measurement of physical activity level;
duration of study and sample size that would result in
the maximal patient benefit. Finally, we hope to identify
the major barriers to physical activity interventions, par-
ticularly with reference to primary care settings.
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